Pictilisib

Pictilisib has been studied in 2 papers since 2026: none in people yet, 1 in animals, 1 in cells; 2 in the past year. The research so far is in animals and cells. The newest story, Nov 1, 2026: “Protein tagging linked to inflammatory signals in human skin cells”.

Intervention

2 papers study it1 more mentions itUpdated

PubChemChEBI

See all 3 papers on pictilisib

At a glance

The findings reach worms or flies, none yet in people. 1 lab; 2 trials, none about aging, 2 with no results posted.

Worms or flies: a single group. Cells, mice and humans: nothing yet.
  • 1 lab
  • 2 trials, none about aging, 2 with no results posted
  • Animals1
  • Cells1

What did lifespan studies of pictilisib find?

DrugAge

DrugAge records 1 result from 1 paper: 1 in C. elegans. Average lifespan is the mean or the median, as each paper reports it.

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 02 papers in 12 months
Cells

Protein tagging linked to inflammatory signals in human skin cells

Two compounds lowered inflammatory signals in lab-grown human skin cells; after 72 hours, fewer cells showed signs of senescence, a state that stops cell division.Two compounds lowered inflammatory signals in lab-grown human skin cells; after 72 hours, fewer cells showed signs of senescence, a state that stops cell division.

Human cell studySkin